Home > News > Recent cases

Sony v SSH [2016] EWHC 2584 (Pat)16 October 2016Andrew Lykiardopoulos QC and James Abrahams QC appeared for the Claimants and Part 20 Defendants in this action dealing with a patent for network communications. The patent in suit was owned by SSH, and related to the use of ‘keepalive’ packets of data when exchanging information between private and public networks through a Network Address […]
Warner Lambert v Generics Ltd, Actavis, Caduceus (Pregabalin) [2016] EWCA Civ 100613 October 2016The Court of Appeal has handed down Judgment on the Pregabalin matter. Richard Meade QC, Adrian Speck QC and Isabel Jamal were instructed by Powell Gilbert for Actavis.
Actavis v ICOS and Lilly [2016] EWHC 1955 (Pat)10 August 2016Members of chambers appeared in this patent action relating to tadalafil, a generic product for treating erectile dysfunction. Actavis, Actelion, Teva and Generics UK (Mylan) sought to “clear the way” in relation to two patents owned by ICOS Corp and of which Eli Lilly and Company were exclusive licencees. Birss J found that EP (UK) […]
Idenix v Gilead [2014] EWHC 3916 (Pat)19 July 2016Andrew Lykiardopoulos QC, Tom Moody-Stuart and William Duncan all acted for Gilead (together with Justin Turner QC) in these patent infringement proceedings brought by Idenix in respect of Gilead’s product “Sovaldi” . The trial was heard over three weeks before Arnold J in 2014, who dismissed Idenix’s claims of patent infringement and held in favour […]
Glaxo Wellcome UK Ltd (t/a Allen & Hansburys) v Sandoz Ltd (High Court) [2016] EWHC 1537 (Ch)28 June 2016This case concerns an ongoing and large scale action for Trade Mark infringement and passing off brought by Glaxo against Sandoz in relation to asthma inhalers. The UK action forms part of a series of international disputes concerning these pharmaceutical products. Glaxo owns a EUTM colour per se trade mark which is visually represented by […]